# Targeting mitochondrial phosphatase PGAM5 alleviates ferroptosis and acute pancreatitis by upregulating NRF2-mediated FSP1 expression

**Authors:** Shuang Ma, Jianhua Qin, Jing Luan, Guoyan Hou, Jiyuan He, Minghui Gao

PMC · DOI: 10.1038/s41419-026-08484-9 · 2026-02-21

## TL;DR

This paper shows that targeting the mitochondrial phosphatase PGAM5 can protect cells from ferroptosis and reduce acute pancreatitis by boosting the antioxidant NRF2-FSP1 pathway.

## Contribution

The study reveals PGAM5 as a novel regulator of ferroptosis through its dual role in stabilizing NRF2 and inducing energy stress.

## Key findings

- PGAM5 dysregulation protects against ferroptosis by upregulating NRF2 and FSP1.
- PGAM5 inhibition reduces acute pancreatitis in a mouse model.
- AMPK activation and energy stress mediate PGAM5's protective effects.

## Abstract

Ferroptosis is a regulated necrosis that is driven by iron-dependent lipid peroxidation. Phosphoglycerate mutase 5 (PGAM5), as a mitochondrial signaling hub, modulates mitochondrial dynamics, senses mitochondrial stress, and regulates the anti-oxidative response. However, the function of PGAM5 in ferroptosis remains elusive. Here, we discovered that PGAM5 emerges as a critical regulator of ferroptosis, with both genetic deletion and overexpression conferring protection against ferroptosis by upregulating nuclear factor erythroid 2-related factor 2 (NRF2) mediated ferroptosis suppressor protein 1 (FSP1) expression. On the one hand, dyregulation of PGAM5 upregulates NRF2 expression transcriptionally and inhibits its polyubiquitination. On the other hand, modulating the expression of PGAM5 results in energy stress ([AMP + ADP]/[ATP] ratio increase) and AMP-activated protein kinase (AMPK) activation. AMPK-dependent phosphorylation of NRF2 drives its nuclear accumulation, where it transcriptionally upregulates FSP1 to promote cell survival. Furthermore, pharmacological inhibition of PGAM5 attenuates arginine-induced acute pancreatitis, highlighting its therapeutic potential. Our findings establish PGAM5 as a central node in ferroptosis regulation and implicate its pathogenic role in acute pancreatitis.

The molecular mechanism of alleviation of ferroptosis by dysregulation of PGAM5.

The molecular mechanism of alleviation of ferroptosis by dysregulation of PGAM5.

## Linked entities

- **Genes:** PGAM5 (PGAM family member 5, mitochondrial serine/threonine protein phosphatase) [NCBI Gene 192111], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275], PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562]
- **Diseases:** acute pancreatitis (MONDO:0006515)

## Full-text entities

- **Genes:** TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031] {aka ARA70, ELE1, PTC3, RFG}, NOX1 (NADPH oxidase 1) [NCBI Gene 27035] {aka GP91-2, MOX1, NOH-1, NOH-1L, NOH1}, MFN2 (mitofusin 2) [NCBI Gene 9927] {aka CMT2A, CMT2A2, CMT2A2A, CMT2A2B, CPRP1, HMSN6A}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, DNM1L (dynamin 1 like) [NCBI Gene 10059] {aka DLP1, DRP1, DVLP, DYMPLE, EMPF, EMPF1}, ATL1 (atlastin GTPase 1) [NCBI Gene 51062] {aka AD-FSP, ATL-1, FSP1, HSN1D, SPG3, SPG3A}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TWIST2 (twist family bHLH transcription factor 2) [NCBI Gene 117581] {aka AMS, BBRSAY, DERMO1, FFDD3, SETLSS, bHLHa39}, Atl1 (atlastin GTPase 1) [NCBI Gene 73991] {aka 4930435M24Rik, Adfsp, Fsp1, Spg3, Spg3a}, PGAM5 (PGAM family member 5, mitochondrial serine/threonine protein phosphatase) [NCBI Gene 192111] {aka BXLBV68}, DHODH (dihydroorotate dehydrogenase (quinone)) [NCBI Gene 1723] {aka DHOdehase, POADS, URA1}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, CUL3 (cullin 3) [NCBI Gene 8452] {aka CUL-3, NEDAUS, PHA2E}, ALOX15 (arachidonate 15-lipoxygenase) [NCBI Gene 246] {aka 12-LOX, 15-LOX, 15-LOX-1, LOG15}, MBOAT1 (membrane bound glycerophospholipid O-acyltransferase 1) [NCBI Gene 154141] {aka LPEAT1, LPLAT, LPLAT 1, LPLAT14, LPSAT, OACT1}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, CST12P (cystatin 12, pseudogene) [NCBI Gene 106478911] {aka Cst, Ctes4, E2}, OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 4976] {aka BERHS, MGM1, MTDPS14, MTDPS14A, MTDPS14B, NPG}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, FTL (ferritin light chain) [NCBI Gene 2512] {aka FTL1, LFTD, NBIA3}
- **Diseases:** inflammatory (MESH:D007249), calcium overload (MESH:D019190), Mitochondrial dysfunction (MESH:D028361), inflammatory response (MESH:D018746), AP (MESH:D010195), fragmentation (MESH:D012892), organ failure (MESH:D009102), pancreatic damage (MESH:D010182), necrosis (MESH:D009336)
- **Chemicals:** paraffin (MESH:D010232), Propidium Iodide (MESH:D011419), Aginine (-), H&amp;E (MESH:D006371), PE (MESH:C483858), NaCl (MESH:D012965), 15-HPETE (MESH:C025086), PI (MESH:D010716), PUFA (MESH:D005231), blasticidin (MESH:C004500), Hematoxylin (MESH:D006416), adrenic acid (MESH:C011395), puromycin (MESH:D011691), erastin (MESH:C477224), penicillin (MESH:D010406), peroxides (MESH:D010545), NP-40 (MESH:C010615), acyl-CoA (MESH:D000214), amino acids (MESH:D000596), EDTA (MESH:D004492), ADP (MESH:D000244), TCA (MESH:D014238), L-arginine (MESH:D001120), MDA (MESH:D008315), streptomycin (MESH:D013307), Lipid hydroperoxides (MESH:D008054), ATP (MESH:D000255), water (MESH:D014867), phospholipid (MESH:D010743), AMP (MESH:D000249), glutamine (MESH:D005973), CO2 (MESH:D002245), Iron (MESH:D007501), lipid (MESH:D008055), cysteine (MESH:D003545), polybrene (MESH:D006583), ubiquinone (MESH:D014451), TRIzol (MESH:C411644), PBS (MESH:D007854), heparin (MESH:D006493), 4-HNE (MESH:C027576), ethanol (MESH:D000431), Glucose (MESH:D005947), ubiquinol (MESH:C003741), ROS (MESH:D017382)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** serine/threonine, S0131S
- **Cell lines:** MEFs — Mus musculus (Mouse), Finite cell line (CVCL_9115), HT1080 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_0317), 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), AC16 — Homo sapiens (Human), Transformed cell line (CVCL_HA69), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966488/full.md

---
Source: https://tomesphere.com/paper/PMC12966488